Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabet E Manasanch

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Hematology. American Society of Hematology. Education Program|December 7, 2019
What to do with minimal residual disease testing in myelomaElisabet E Manasanch
Seminars in Oncology|January 8, 2017
Recommend maintenance therapy with lenalidomide in multiple myelomaElisabet E Manasanch
Best Practice & Research. Clinical Haematology|March 7, 2020
High-risk smoldering myeloma versus early detection of multiple myeloma: Current models, goals of therapy, and clinical implicationsChutima Kunacheewa, Elisabet E Manasanch
Expert Review of Hematology|September 22, 2021
The benefits of early intervention using lenalidomide for high-risk smoldering multiple myeloma: emerging data and its promising clinical impactChutima Kunacheewa, Elisabet E Manasanch
Nature Reviews. Clinical Oncology|January 25, 2017
Proteasome inhibitors in cancer therapyElisabet E Manasanch, Robert Z Orlowski
Oncotargets and Therapy|March 1, 2017
Carfilzomib boosted combination therapy for relapsed multiple myelomaRaphael E Steiner, Elisabet E Manasanch
Leukemia & Lymphoma|October 25, 2022
The role of soluble B cell maturation antigen as a biomarker in multiple myelomaMohammed Alomari, Chutima Kunacheewa, Elisabet E Manasanch
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2013
Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditionsElisabet E Manasanch, Sigurdur Y Kristinsson, Ola Landgren
The Oncologist|March 22, 2015
Gefitinib and erlotinib in metastatic non-small cell lung cancer: a meta-analysis of toxicity and efficacy of randomized clinical trialsMauricio Burotto, Elisabet E Manasanch, Julia Wilkerson, et al.
European Journal of Haematology|October 12, 2013
Smoldering multiple myeloma: present position and potential promisesNishant Tageja, Elisabet E Manasanch, Neha Korde, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Hematology. American Society of Hematology. Education Program|December 7, 2019
What to do with minimal residual disease testing in myelomaElisabet E Manasanch
Seminars in Oncology|January 8, 2017
Recommend maintenance therapy with lenalidomide in multiple myelomaElisabet E Manasanch
Best Practice & Research. Clinical Haematology|March 7, 2020
High-risk smoldering myeloma versus early detection of multiple myeloma: Current models, goals of therapy, and clinical implicationsChutima Kunacheewa, Elisabet E Manasanch
Expert Review of Hematology|September 22, 2021
The benefits of early intervention using lenalidomide for high-risk smoldering multiple myeloma: emerging data and its promising clinical impactChutima Kunacheewa, Elisabet E Manasanch
Nature Reviews. Clinical Oncology|January 25, 2017
Proteasome inhibitors in cancer therapyElisabet E Manasanch, Robert Z Orlowski
Oncotargets and Therapy|March 1, 2017
Carfilzomib boosted combination therapy for relapsed multiple myelomaRaphael E Steiner, Elisabet E Manasanch
Leukemia & Lymphoma|October 25, 2022
The role of soluble B cell maturation antigen as a biomarker in multiple myelomaMohammed Alomari, Chutima Kunacheewa, Elisabet E Manasanch
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2013
Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditionsElisabet E Manasanch, Sigurdur Y Kristinsson, Ola Landgren
The Oncologist|March 22, 2015
Gefitinib and erlotinib in metastatic non-small cell lung cancer: a meta-analysis of toxicity and efficacy of randomized clinical trialsMauricio Burotto, Elisabet E Manasanch, Julia Wilkerson, et al.
European Journal of Haematology|October 12, 2013
Smoldering multiple myeloma: present position and potential promisesNishant Tageja, Elisabet E Manasanch, Neha Korde, et al.
Pageof 6